Zhike pingchuan granules improve bronchial asthma by regulating the IL-6/JAK2/STAT3 pathway

Exp Ther Med. 2021 Aug;22(2):899. doi: 10.3892/etm.2021.10331. Epub 2021 Jun 23.

Abstract

The present study aimed to investigate the effects of zhike pingchuan granules (ZKPC) on bronchial asthma and the underlying mechanism. A bronchial asthma mouse model was established by aerosol inhalation of ovalbumin. The changes in lung pathomorphology were observed by hematoxylin and eosin staining. The levels of IL-1β, TNF-α and IL-6 in bronchoalveolar lavage fluid (BALF) and serum were detected by corresponding ELISA kits. Levels of reactive oxygen species, malondialdehyde and superoxide dismutase in lung tissues were analyzed using corresponding kits. The expression of proteins related to apoptosis and the IL-6/janus kinase 2 (JAK2)/STAT3 pathway was detected by western blot analysis. The results showed that ZKPC significantly restored the dry/wet ratio and alleviated lung pathomorphology of bronchial asthmatic mice. In addition, ZKPC inhibits inflammation, oxidative stress levels and cell apoptosis in bronchial asthmatic mice and also suppressed the IL-6/JAK2/STAT3 pathway. Fedratinib (a JAK2 inhibitor) further strengthened the alleviative effects of ZKPC on bronchial asthma. In conclusion, ZKPC improved bronchial asthma by suppressing the IL-6/JAK2/STAT3 pathway.

Keywords: IL-6/janus kinase 2/STAT3 pathway; bronchial asthma; inflammation; zhike pingchuan granules.

Grants and funding

Funding: This study was supported by grants from the National Natural Science Foundation project: Experimental study on the regulation of TGF-1/VEGF expression in airway remodeling in asthmatic rats based on the new theory of ‘hidden wind stagnation and lodge phlegm’ pathogenesis (grant no. 81574020). Traditional Chinese Medicine Scientific Research Special Project of Henan Province (grant no. 20-21ZY2057); Henan Provincial Key Research and Development and Promotion Special Project (Science and Technology Targeted) (grant no. 212102311143)